Rockwell Medical, Inc. - Common Stock (RMTI)
1.4000
-0.3600 (-20.45%)
Rockwell Medical is a biopharmaceutical company that focuses on developing and providing innovative treatments for patients with chronic kidney disease and end-stage renal disease
The company specializes in therapies aimed at addressing the complications associated with these conditions, particularly iron deficiency anemia. Rockwell Medical is engaged in the research and development of solutions that enhance the quality of life for patients undergoing dialysis and other renal care, aiming to improve patient outcomes through effective medical interventions.
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · March 20, 2025
Via Benzinga · March 20, 2025
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via Chartmill · March 20, 2025
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via Chartmill · March 20, 2025
Via Benzinga · March 20, 2025

Rockwell Medical enters multi-year agreement with leading dialysis provider, expected to generate $10M+ in first year.
Via Benzinga · December 17, 2024

Via Benzinga · November 14, 2024

Rockwell Medical Inc (NASDAQ: RMTI) reported a Q2 FY23 revenue of $18.1 million,
Via Benzinga · August 14, 2023

Via Benzinga · November 12, 2024

RMTI stock results show that Rockwell Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024

Via Benzinga · May 13, 2024

Via Benzinga · March 22, 2024

RMTI stock results show that Rockwell Medical beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 21, 2024

We are diving into the biggest pre-market stock movers with all of the most recent news worth reading about on Thursday morning!
Via InvestorPlace · March 21, 2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via Benzinga · March 21, 2024

Via Benzinga · August 16, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Via Benzinga · August 14, 2023